<progress id="lf1fn"><big id="lf1fn"><del id="lf1fn"></del></big></progress>
<nobr id="lf1fn"></nobr>
<meter id="lf1fn"><track id="lf1fn"><dl id="lf1fn"></dl></track></meter>

<em id="lf1fn"></em>

      <em id="lf1fn"></em>

        <meter id="lf1fn"></meter>

          Company History

          Your current location:Home > About Lonzeal > Company History

          2006 Lonzeal Pharmaceuticals was established

          2008 The production base of Lonzeal Pharmaceuticals was put into operation

          2010 Obtained the GMP certificate of raw materials from the State Food and Drug Administration of China

          2012 Passed the GMP on-site inspection of the World Health Organization

          From 2012 to 2015, API products have been registered in Brazil, Russia, South Africa and other countries

          2017 Passed the GMP on-site inspection of multiple anti-AIDS APIs by the World Health Organization

          2018 Zero defect passed the US FDA's API GMP on-site inspection

          2019 Anti-AIDS and hepatitis B preparation products took the lead in passing the consistency evaluation

          2021 Paroxetine Hydrochloride, Tenofovir Alafenamide Fumarate, and Pregabalin passed the consistency evaluation and obtained drug registration approval

          About Lonzeal

          Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.

          Domestic sales center:17703115689    liuyu@lonzeal.com
          International Sales Center:15931139631    emma@lonzeal.com
          Human Resource Center:0311-87512081    lzzyhr@lonzeal.com
          Address: Shenze County Industrial Park, Shijiazhuang City, Hebei Province (No. 16 West Ring Road)

          WeChat qr code
          Copyright:Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.   冀ICP備09039052號-1
          黄 色 a 片 免 费 看 视 频